Related Experiment Video
Updated: Mar 9, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Vladimir Stanislavovich Rogovskii1
1Department of Molecular Pharmacology and Radiobiology, Pirogov Russian National Research Medical University, Bolshaya Pirogovskaya st. 9a, Moscow, 119435, Russian Federation.
Background:
It is widely accepted that chronic inflammation critically contributes to cancer. Immune tolerance in cancer mediates tumor escape from the immune system. The mechanisms of relations between inflammation and immune tolerance are still not fully elucidated.
Objective:
The main mechanisms that link inflammation and tolerance are considered. Drug targets that are in use to interfere with inflammation in cancer are discussed.
Conclusion:
Inflammation mediates tumor-induced tolerance. The induction and the maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.
Insights
Chronic inflammation drives cancer progression by promoting immune tolerance, allowing tumors to evade immune detection. Understanding these links is crucial for developing new cancer therapies.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Chronic inflammation is a critical factor in cancer development.
- Immune tolerance in cancer facilitates tumor escape from immune surveillance.
- The precise mechanisms linking inflammation and immune tolerance in cancer remain incompletely understood.
Purpose of the Study:
- To elucidate the primary mechanisms connecting inflammation and immune tolerance in the context of cancer.
- To review current drug targets aimed at modulating inflammation in cancer treatment.
Main Methods:
- Review and synthesis of existing scientific literature on inflammation and immune tolerance in cancer.
- Analysis of established and emerging therapeutic strategies targeting inflammatory pathways in oncology.
Main Results:
- Inflammation plays a key role in mediating tumor-induced immune tolerance.
- The induction and sustained presence of chronic inflammation represent a common strategy employed by tumors to establish immune tolerance.
Conclusions:
- Inflammation is a fundamental driver of tumor-induced immune tolerance.
- Targeting inflammatory pathways offers potential therapeutic avenues for overcoming immune evasion in cancer.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
The Tumor Microenvironment
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy
